Neuronal differentiation by analogs of staurosporine

Neurochemistry International

Volumn 56, Issue 4, 2010, Pages 554-560

  Thompson, Alex F ^a   Levin, Leonard A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Kinase inhibition; Neuronal differentiation; Retinal ganglion cells; Staurosporine; Structure function

Indexed keywords

7 HYDROXYSTAUROSPORINE; K 252 C; K 252A; K 252B; MIDOSTAURIN; STAUROSPORINE; STAUROSPORINE AGLYCONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; MOLECULAR MECHANICS; MOUSE; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETINA GANGLION CELL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

3T3 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; MICE; NEURITES; NEURONS; PC12 CELLS; PROTEIN KINASE INHIBITORS; RATS; STAUROSPORINE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTIONAL ACTIVATION;

EID: 77249106474     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.12.018     Document Type: Article

References (27)

1. Bain J., McLauchlan H., Elliott M., and Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371 (2003) 199-204
2. Bertrand R., Solary E., O'Connor P., Kohn K.W., and Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211 (1994) 314-321
3. Bhonde M.R., Hanski M.L., Magrini R., Moorthy D., Muller A., Sausville E.A., Kohno K., Wiegand P., Daniel P.T., Zeitz M., and Hanski C. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein. Oncogene 24 (2005) 148-156
4. Fabbro D., Ruetz S., Bodis S., Pruschy M., Csermak K., Man A., Campochiaro P., Wood J., O'Reilly T., and Meyer T. PKC412-a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des. 15 (2000) 17-28
5. Frassetto L.J., Schlieve C.R., Lieven C.J., Utter A.A., Jones M.V., Agarwal N., and Levin L.A. Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest. Ophthalmol. Vis. Sci. 47 (2006) 427-438
6. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 2424-2428
7. Hashimoto S., and Hagino A. Staurosporine-induced neurite outgrowth in PC12h cells. Exp. Cell Res. 184 (1989) 351-359
8. Hirose M., Ishizaki T., Watanabe N., Uehata M., Kranenburg O., Moolenaar W.H., Matsumura F., Maekawa M., Bito H., and Narumiya S. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell. Biol. 141 (1998) 1625-1636
9. Horton P.A., Longley R.E., McConnell O.J., and Ballas L.M. Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian Eudistoma sp. Experientia 50 (1994) 843-845
10. Jalava A., Heikkila J., Lintunen M., Akerman K., and Pahlman S. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA). FEBS Lett. 300 (1992) 114-118
11. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., and Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142 (1987) 436-440
12. Koizumi S., Contreras M.L., Matsuda Y., Hama T., Lazarovici P., and Guroff G. K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells. J. Neurosci. 8 (1988) 715-721
13. Krishnamoorthy R.R., Agarwal P., Prasanna G., Vopat K., Lambert W., Sheedlo H.J., Pang I.H., Shade D., Wordinger R.J., Yorio T., Clark A.F., and Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Res. Mol. Brain Res. 86 (2001) 1-12
14. Kukkonen J.P., Shariatmadari R., Courtney M.J., and Akerman K.E. Localization of voltage-sensitive Ca2+ fluxes and neuropeptide Y immunoreactivity to varicosities in SH-SY5Y human neuroblastoma cells differentiated by treatment with the protein kinase inhibitor staurosporine. Eur. J. Neurosci. 9 (1997) 140-150
15. Lieven C.J., Millet L.E., Hoegger M.J., and Levin L.A. Induction of axon and dendrite formation during early RGC-5 cell differentiation. Exp. Eye Res. 85 (2007) 678-683
16. Lombet A., Zujovic V., Kandouz M., Billardon C., Carvajal-Gonzalez S., Gompel A., and Rostene W. Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family. Eur. J. Biochem. 268 (2001) 1352-1362
17. Morioka H., Ishihara M., Shibai H., and Suzuki T. Staurosporine-induced differentiation in a human neuroblastoma cell line, NB-1. Agric. Biol. Chem. 49 (1985) 1959-1963
18. Pittman R.N., Wang S., DiBenedetto A.J., and Mills J.C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13 (1993) 3669-3680
19. Rasouly D., Shavit D., Zuniga R., Elejalde R.B., Unsworth B.R., Yayon A., Lazarovici P., and Lelkes P.I. Staurosporine induces neurite outgrowth in neuronal hybrids (PC12EN) lacking NGF receptors. J. Cell. Biochem. 62 (1996) 356-371
20. Ruegg U.T., and Burgess G.M. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10 (1989) 218-220
21. Scaife R.M., Job D., and Langdon W.Y. Rapid microtubule-dependent induction of neurite-like extensions in NIH 3T3 fibroblasts by inhibition of ROCK and Cbl. Mol. Biol. Cell 14 (2003) 4605-4617
22. Schwechter B.R., Millet L.E., and Levin L.A. Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. Invest. Ophthalmol. Vis. Sci. 48 (2007) 2845-2857
23. Shea T.B., and Beermann M.L. Staurosporine-induced morphological differentiation of human neuroblastoma cells. Cell. Biol. Int. Rep. 15 (1991) 161-168
24. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., and Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem. Biophys. Res. Commun. 135 (1986) 397-402
25. Tischler A.S., Ruzicka L.A., and Perlman R.L. Mimicry and inhibition of nerve growth factor effects: interactions of staurosporine, forskolin, and K252a in PC12 cells and normal rat chromaffin cells in vitro. J. Neurochem. 55 (1990) 1159-1165
26. Todaro G.J., and Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell. Biol. 17 (1963) 299-313
27. Yao R., Yoshihara M., and Osada H. Specific activation of a c-Jun NH2-terminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine. J. Biol. Chem. 272 (1997) 18261-18266